Skip to main content

HCMA and the Lori Fund

Navigation to hypertrophic cardiomyopathy centres of excellence, plus a fund that covers travel costs to reach one.

Transportation, lodging, or foodHeart and circulationCondition-specific help

Best for

People with hypertrophic cardiomyopathy who need specialist care that is not available locally.

Why Kave includes this

HCM is common enough to matter and rare enough that most cardiologists see few cases, so getting to a specialist centre changes management substantially. The travel fund addresses the barrier that actually stops people: the specialist is free at the point of referral, and the flight is not.

Limitations Kave wants you to know about

  • Hypertrophic cardiomyopathy specifically — not general heart disease.
  • Travel funds are limited and awarded case by case.
  • Covers travel, not the medical care itself.

Verification

Compiled by Kave on July 1, 2026 and link-checked. Not yet independently verified. Kave assembled this from the organisation’s own published material and confirmed the links resolve. No reviewer has confirmed the eligibility details against the source, so check them on the official site before you rely on them.

Compiled
July 1, 2026 (28 days ago)
Next scheduled review
September 29, 2026
Reviewed by
Not yet reviewed

Sources used

Kave quality score

82/100

Kave lists resources scoring 80 or above that also clear all four mandatory gates.

  • Patient impact21.5/25
  • Affordability or financial value17.6/20
  • Transparency12/15
  • Accessibility10.8/15
  • Ease of use7.4/10
  • Geographic reach4.4/5
  • Institutional credibility4.3/5
  • Privacy and data practices4.2/5

Geographic reach is deliberately worth only five points, so a strong local resource is not pushed out by a weak national one. Read the methodology.

HCMA and the Lori Fund | Kave Health